Recent years, it has been believed that insulin resistance (IR) is the independent risk factor of dyslipidemia, systemic inflammation, oxidative stress. Nowadays in different sources we can find quite contradictory facts about the role of polymorphism insulin receptor substrate-1 (IRS-1) in the development of IR and its consequences.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Atherosclerosis
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2015 Published by Elsevier Inc.